SLITRK2 Activators
The activators listed for SLITRK2 primarily focus on methods of activation or modulation, considering SLITRK2's role in neuronal development and function. These chemicals influence neurotrophic factors, neurotransmitter signaling, and cellular development pathways, which can lead to the modulation of SLITRK2 activity or expression. Neurotrophic factors like BDNF and NGF, and compounds like retinoic acid and lithium, play significant roles in neural development and could influence SLITRK2. Antidepressants like fluoxetine and neuroactive drugs such as VPA might impact SLITRK2 by altering neurotransmitter systems.
GABA agonists and glutamate receptor modulators can affect neurotransmission and synaptic function, influencing SLITRK2. Similarly, modulators of Wnt signaling, HDAC inhibitors, and mTOR inhibitors can impact neurodevelopmental processes and epigenetic regulation, affecting SLITRK2 expression. Understanding these activators or modulators of SLITRK2 is important for research in neuroscience, particularly in studies of neuronal development and neurodevelopmental disorders.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $65.00 $319.00 $575.00 $998.00 | 28 | |
As a regulator of neuronal development, retinoic acid could influence SLITRK2 expression by modulating gene expression in neural cells. | ||||||
Lithium | 7439-93-2 | sc-252954 | 50 g | $214.00 | ||
Lithium, known to affect neurodevelopmental pathways, might indirectly impact SLITRK2 through its role in modulating neuronal signaling and neuroplasticity. | ||||||
Fluoxetine | 54910-89-3 | sc-279166 | 500 mg | $312.00 | 9 | |
Fluoxetine, an antidepressant, may indirectly influence SLITRK2 expression by affecting serotonergic signaling, which is involved in neurodevelopment and neuronal function. | ||||||
Valproic Acid | 99-66-1 | sc-213144 | 10 g | $85.00 | 9 | |
VPA, used in neurological disorders, could indirectly impact SLITRK2 expression by modulating neuronal signaling pathways and exerting neuroprotective effects. | ||||||
Thymosin β4 | 77591-33-4 | sc-396076 sc-396076A | 1 mg 100 mg | $134.00 $7140.00 | ||
TGF-β, involved in cellular development processes, might influence SLITRK2 expression indirectly through its regulatory effects on neuronal cells. | ||||||